NDC 0409-1808 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1808
- Package NDCs from labels
- 0409-1808-02, 0409-1808-06
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1808-02 | Novocain | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 1 | |
| 0409-1808-02 | Novocain | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 1 | |
| 0409-1808-06 | Novocain | 50 in 1 TRAY | INJECTION, SOLUTION | 50 | 1 | |
| 0409-1808-06 | Novocain | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Plegisol | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Hospira, Inc. | 35a174f0-f0d7-4ec7-3f81-d3d572c059cf | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| THAM | TROMETHAMINE | Hospira, Inc. | 4af52118-c12b-4ad5-30bb-959848357e8a | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | 8535cc84-ad4a-4d67-8480-fb5a2e3406f8 | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| DOBUTAMINE | DOBUTAMINE | Hospira, Inc. | 89becb0c-da60-4f43-0a98-29ff7a9eca58 | 2026-05-27 | Warnings, Adverse reactions | Hospira, Inc. |
| TPN Electrolytes | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS | Hospira, Inc. | c00817bc-7b62-4abe-0280-e7930eda3f94 | 2026-05-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Hospira, Inc. | 67908e20-044d-454d-9c51-bf106e817bd0 | 2026-05-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Heparin Sodium and Dextrose | HEPARIN SODIUM | Hospira, Inc. | eede8a0c-5ae6-4166-84b3-12081405f08e | 2026-05-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Diltiazem Hydrochloride | DILTIAZEM HYDROCHLORIDE | Hospira, Inc. | bba03666-ff4f-4bf6-fa92-78e1ec2d9073 | 2026-05-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Ondansetron | ONDANSETRON | Hospira, Inc. | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 2026-05-23 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 89a4bd73-89f4-4fd7-2c9f-921e1da8f96b | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Diazepam | DIAZEPAM | Hospira, Inc. | 7e7dd743-a87b-4ab3-b6ae-f116cd0c8b0f | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Acetylcysteine | ACETYLCYSTEINE | Hospira, Inc. | 5558a5f5-e821-473b-7d8a-5d33d09f0586 | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| LMD in Dextrose | DEXTRAN 40 | Hospira, Inc. | 3c273512-84e2-2cea-b201-12345a6bd1fe | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Aminophylline | AMINOPHYLLINE | Hospira, Inc. | 9a663ef3-881f-48bd-2689-3713b24545c2 | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Ondansetron | ONDANSETRON | Hospira, Inc. | 6a11f61b-2318-4382-2b91-4366e4bb53fa | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Hospira, Inc. | 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7 | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Hospira, Inc. | 7c1f998a-233d-4feb-6ea2-457702abd0d2 | 2026-05-21 | Warnings, Adverse reactions | Hospira, Inc. |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 548a88c0-afda-427e-75ac-5af0cfa2224c | 2026-05-20 | Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.